Donor Neutrophil Subsets to Predict the Risk of aGVHD

Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation

NCT07235501 ·Status: NOT_YET_RECRUITING

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

NCT00898612 ·Status: WITHDRAWN

Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study

NCT06386445 ·Status: NOT_YET_RECRUITING

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies

NCT06294678 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Prospective and Retrospective Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia (Acute Leukemia HSCT Cohort)

NCT02344953 ·Status: UNKNOWN

The Polarization and Expression of Chemokine Receptors of T Help Cell in the Pathogenesis of Acute and Chronic GVHD

NCT00207922 ·Status: UNKNOWN

Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells

NCT07150468 ·Status: COMPLETED

A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF

NCT00208949 ·Status: TERMINATED ·Phase: PHASE2

Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT

NCT06334367 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT

NCT02398708 ·Status: COMPLETED

Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.

NCT06208137 ·Status: RECRUITING ·Phase: NA

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

NCT00003538 ·Status: COMPLETED ·Phase: NA

Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation

NCT03357172 ·Status: RECRUITING ·Phase: NA

Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

NCT07349498 ·Status: RECRUITING

Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCT

NCT06143501 ·Status: RECRUITING

Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut

NCT07305090 ·Status: RECRUITING

Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

NCT00143884 ·Status: TERMINATED ·Phase: PHASE2

Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation

NCT01206309 ·Status: COMPLETED

Efficacy and Safety of Auto-FMT in Preventing aGVHD

NCT04745221 ·Status: RECRUITING ·Phase: NA

Multiparametric Ultrasound Study in Diagnosing GvHD

NCT05790135 ·Status: SUSPENDED ·Phase: NA

Granulocyte Transfusion Study

NCT00000581 ·Status: COMPLETED ·Phase: PHASE3

The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCT

NCT06864598 ·Status: ENROLLING_BY_INVITATION

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

NCT00813501 ·Status: TERMINATED

Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells

NCT00770523 ·Status: COMPLETED

FMT In High-Risk Acute GVHD After ALLO HCT

NCT04139577 ·Status: COMPLETED ·Phase: PHASE1